Education
About Us
Working with TipRanks
Follow Us
Nathan D. Jorgensen Insider Profile
4 Followers
Nathan D. Jorgensen, CFO at Vor Biopharma, holds 151.42K shares in Voyager Therapeutics (Ticker: VYGR), holds 189.40K shares in Vor Biopharma (Ticker: VOR). Most recently, Nathan D. Jorgensen Sold ― shares of Voyager Therapeutics on Feb 26, 2026 for an estimated value of $17.60K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+8.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nathan D. Jorgensen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nathan D. Jorgensen
Nathan D. Jorgensen's Trading History
Vor Biopharma
May 07, 2024
CFO
Uninformative Sell
1.46K
$3.01M
Voyager Therapeutics
Feb 26, 2026
CFO
Informative Sell
17.60K
$628.38K
List of latest transactions for each holding click on a transaction to see Nathan D. Jorgensen's performance on stock
You May Also Like
Nathan D. Jorgensen insider profile FAQ
What is the percentage of profitable transactions made by Nathan D. Jorgensen?
The percentage of profitable transactions made by Nathan D. Jorgensen is 100%.
What is the average return per transaction made by Nathan D. Jorgensen?
The average return per transaction made by Nathan D. Jorgensen is 8.10%.
What stocks does Nathan D. Jorgensen hold?
Nathan D. Jorgensen holds: VOR, VYGR stocks.
What was Nathan D. Jorgensen’s latest transaction?
Nathan D. Jorgensen latest transaction was an Informative Sell of $17.60K.
What was Nathan D. Jorgensen's most profitable transaction?
Nathan D. Jorgensen’s most profitable transaction was an Informative Sell of VYGR stock on October 7, 2025. The return on the trade was 13.30%.
What is Nathan D. Jorgensen's role in Vor Biopharma?
Nathan D. Jorgensen's role in Vor Biopharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.